As further support of the reproducibility of our model, we observed that the subcutaneous injection of primary LAM/TSC cells induced cutaneous lesions and follicular neogenesis similarly to what was observed for TSC2-/meth cells. Here, TSC1 is linked to lymphangioleiomyomatosis.